Effect of ecosprin on pulsatility index of uterine artery in all trimesters of pregnancy – cross sectional interventional study in Indian pregnant women

Mamta Singh; Sparsh Singh

doi:10.18203/2320-1770.ijrcog20263028

Authors

Mamta Singh Sparsh Hospital, Kannauj, Uttar Pradesh, India
Sparsh Singh Sparsh Hospital, Kannauj, Uttar Pradesh, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20263028

Keywords:

Low-dose aspirin, Preeclampsia prevention, Uterine artery Doppler, Pulsatility index, Antenatal care, Low-risk pregnancy

Abstract

Background: Low-dose aspirin is recommended to prevent preeclampsia in high-risk pregnancies, primarily by enhancing placental perfusion. However, its routine efficacy in low-risk pregnancies and its direct impact on uterine artery hemodynamic remain under evaluation. This study investigated the effect of low-dose aspirin (75 mg/day) on uterine artery Doppler indices across all trimesters in a low-risk Indian population.

Methods: A prospective interventional study was conducted among 279 low-risk pregnant women attending a tertiary care hospital from March 2024 to December 2025. Participants were divided into a study group (n=115) receiving 75 mg aspirin daily at bedtime following ultrasonographic confirmation of fetal cardiac activity, and a control group (n=164). Uterine artery pulsatility index (UtA-PI) was assessed via Doppler ultrasonography across the first (11-14 weeks), second (18-22 weeks), and third (28-35 weeks) trimesters.

Results: Across all three trimesters, there was no statistically significant difference in mean UtA-PI between the study group and the control group (p>0.05). However, clinical outcomes varied notably: 2.94% of women in the control group developed preeclampsia, whereas 0% of participants in the low-dose aspirin study group developed preeclampsia.

Conclusions: Although low-dose aspirin (75 mg/day) did not significantly alter uterine artery Doppler pulsatility indices compared to controls, it demonstrated a clear clinical benefit by completely preventing preeclampsia. Given its high safety profile and low cost, universal initiation of low-dose aspirin early in pregnancy may serve as a valuable prophylactic strategy in low-resource settings where formal risk-stratification testing is unfeasible.

References

World Health Organization. WHO recommendations for prevention and treatment of pre-eclampsia and eclampsia. Geneva (Switzerland), 2011. Available at: http://apps.who.int/iris/bitstream/10665/44703/1/9789241548335_eng.pdf. Accessed on 15 July 2026.

Duley L, Henderson-Smart DJ, Meher S, King JF. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev. 2007:(2):CD004659.

Askie LM, Duley L, Henderson-Smart DJ, Stewart LA. Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data. PARIS Collaborative Group. Lancet. 2007;369(9575):1791-8.

Henderson JT, Whitlock EP, O’Connor E, Senger CA, Thompson JH, Rowland MG. Low-dose aspirin for prevention of morbidity and mortality from preeclampsia: a systematic evidence review for the U.S. Preventive Services Task Force. Ann Intern Med. 2014;160:695-703.

Ahrens KA, Silver RM, Mumford SL, Sjaarda LA, Perkins NJ, Wactawski-Wende J, et al. Complications and safety of preconception low-dose aspirin among women with prior pregnancy losses. Obstet Gynecol. 2016;127:689-98.

Whittlesea C, Hodson K. Clinical pharmacology. 6th edition. Elsevier; 2018.

World Health Organization International Collaborative Study of Hypertensive Disorders of Pregnancy. Geographic variation in the incidence of hypertension in pregnancy. Am J Obstet Gynecol. 1988;158(1):80-3.

Khan KS, Wojdyla D, Say L, Gulmezoglu AM, Van Look PF. WHO analysis of causes of maternal death: a systematic review. Lancet. 2006;367(9516):1066-74.

Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet. 2005;365(9461):785-99.

Brosens I, Robertson WB, Dixon HG. The physiological response of the vessels of the placental bed to normal pregnancy. J Pathol Bacteriol. 1967;93(2):569-79.

Khong TY, De Wolf F, Robertson WB, Brosens I. Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants. Br J Obstet Gynaecol. 1986;93(10):1049-59.

Pijnenborg R, Dixon G, Robertson WB, Brosens I. Trophoblastic invasion of human decidua from 8 to 18 weeks of pregnancy. Placenta. 1980;1(1):3-19.

De Wolf F, DeWolf-Peeters C, Brosens I, Robertson W. The human placental bed: electron microscopic study of trophoplastic invasion of spiral arteries. Am J Obstet Gynecol. 1980;137(1):58-70.

Staff AC, Benton SJ, Dadelszen PV, Roberts JM, Taylor RN, Powers RW, et al. Redefining pre-eclampsia using placenta-derived biomarkers. Hypertension. 2013;61(5):932-42.

Brown MA, Lindheimer MD, Swiet MD, Assche AV, Moutquin JM. The classification and diagnosis of hypertensive disorders of pregnancy: statement from the international Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy. 2001;20(1):9-12.

Villa PM, Kajantie E, Räikkönen K, Pesonen AK, Hämäläinen E, Vainio M, et al. Aspirin in the prevention of pre-eclampsia in high-risk women: a randomized placebo controlled PREDO trial and a meta-analysis of randomised trials. BJOG. 2013;120(1):64-74.

Duley L, Meher S, Hunter KE, Seidler AL, Askie LM. Antiplatelet agents for preventing preeclampsia and its complications. Cochrane Database Syst Rev. 2019;2019(10):CD004659.

Roberge S, Villa P, Nicolaides K, Giguère Y, Vainio M, Bakthi A, et al. Early administration of low-dose aspirin for the prevention of preterm and term preeclampsia: a systematic review and meta-analysis. Fetal Diagn Ther. 2012;31(3):141-6.

Yu CKH, Papageorghiou AT, Parra M, Dias RP, Nicolaides KH, Fetal Medicine Foundation Second Trimester Screening Group. Randomized controlled trial using low-dose aspirin in the prevention of pre-eclampsia in women with abnormal uterine artery Doppler at 23 weeks' gestation. Ultrasound Obstet Gynecol. 2003;22(3):233-9.

Low dose aspirin in pregnancy and early childhood development: follow up of the collaborative low dose aspirin study in pregnancy. Br J Obstet Gynaecol. 1995;102(11):861-8.

National Collaborating Centre for Women's and Children's Health (UK). The National Institute for Health and Clinical Excellence. The Management of Hypertensive Disorders During Pregnancy. London: RCOG Press; 2010.

Rolnik DL, Wright D, Poon LC, O'Gorman N, Syngelaki A, Matallana CDP, et al. Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia. N Engl J Med. 2017;377(7):613-22.

LeFevre ML, U.S. Preventive Services Task Force. Low-dose aspirin use for the prevention of morbidity and mortality from preeclampsia: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2014;161(11):819-26.

Bhide A, Acharya G, Bilardo CM, Brezinka C, Cafici D, Hernandez-Andrade E, et al. ISUOG practice guidelines: use of Doppler ultrasonography in obstetrics. Ultrasound Obstet Gynecol. 2013;41(2):233-9.